NEW YORK, July 16 (Reuters) - Merck & Co. (MRK.N) said on Monday its new vaccines Gardasil and Rotateq have been adopted by all projects under a U.S. government immunization program for children.
Rotateq is used against rotavirus, while Gardasil is for the prevention of cervical cancer.
Merck said the two vaccines have been adopted by all 55 U.S.-based immunization projects of the Centers for Disease Control and Prevention’s Vaccines for Children program.
(Reporting by Lewis Krauskopf)
((Editing by Gerald E. McCormick; Reuters Messaging: Lewis.Krauskopf.email@example.com; firstname.lastname@example.org; 646-223-6082)) Keywords: MERCK VACCINES/
C Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWNAS6038